Medical Science Liaison (Psychiatry) - Upstate NY, VT, NH

• Identify, establish, and maintain clinical and scientific relationships with Key Thought Leaders (KTLs) and Developing Thought Leaders (DTLs), including physicians, NPs, pharmacists and researchers
• Act as vital conduit to investigators and key organizations interested in developing research collaborations with Alkermes
• Engage with clinical investigators in support of Alkermes sponsored studies as appropriate
• Attend and provide Medical Affairs support at scientific conferences
• Support internal stakeholders by providing subject matter expertise
• Respond, as appropriate, to unsolicited requests for medical/scientific information
• Provide clinical presentations and educational information in academic, community and healthcare provider settings
• Share insights from the field with appropriate internal colleagues
• Adhere to all Alkermes policies and procedures

Alkermes has an established Medical Science Liaison (MSL) team for CNS, with a current focus in Psychiatry. The team is responsible for creating a respected and valued presence with researchers and thought leaders working in Psychiatry. The MSLs engage in fair balanced scientific exchange with key stakeholders and respond to requests for information about Alkermes products and diseases of interest. Through a thorough understanding of national/regional experts and treatment landscapes, the MSL will gain insight into emerging trends. These insights will help shape medical strategy.

Why join Team Alkermes?

Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.

We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts' Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.

Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.